These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 22892644)

  • 21. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis.
    Kim B; Tang Q; Biswas PS; Xu J; Schiffelers RM; Xie FY; Ansari AM; Scaria PV; Woodle MC; Lu P; Rouse BT
    Am J Pathol; 2004 Dec; 165(6):2177-85. PubMed ID: 15579459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. METTL3-mediated m
    Wang W; Ye W; Chen S; Tang Y; Chen D; Lu Y; Wu Z; Huang Z; Ge Y
    Cell Signal; 2023 Sep; 109():110784. PubMed ID: 37356601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor.
    Suryawanshi A; Mulik S; Sharma S; Reddy PB; Sehrawat S; Rouse BT
    J Immunol; 2011 Mar; 186(6):3653-65. PubMed ID: 21325621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpesvirus entry mediator on radiation-resistant cell lineages promotes ocular herpes simplex virus 1 pathogenesis in an entry-independent manner.
    Edwards RG; Kopp SJ; Karaba AH; Wilcox DR; Longnecker R
    mBio; 2015 Oct; 6(5):e01532-15. PubMed ID: 26489863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How herpes simplex virus type 1 rescinds corneal privilege.
    Lepisto AJ; Frank GM; Hendricks RL
    Chem Immunol Allergy; 2007; 92():203-212. PubMed ID: 17264496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of Herpes Stromal Keratitis: Immune Inflammatory Response Mediated by Inflammatory Regulators.
    Wang L; Wang R; Xu C; Zhou H
    Front Immunol; 2020; 11():766. PubMed ID: 32477330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corneal neovascularization.
    Nicholas MP; Mysore N
    Exp Eye Res; 2021 Jan; 202():108363. PubMed ID: 33221371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis and management of herpes simplex virus keratitis.
    Tullo A
    Eye (Lond); 2003 Nov; 17(8):919-22. PubMed ID: 14631397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes simplex keratitis.
    Kaye S; Choudhary A
    Prog Retin Eye Res; 2006 Jul; 25(4):355-80. PubMed ID: 16807055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corneal neovascularization: updates on pathophysiology, investigations & management.
    Sharif Z; Sharif W
    Rom J Ophthalmol; 2019; 63(1):15-22. PubMed ID: 31198893
    [No Abstract]   [Full Text] [Related]  

  • 31. Corneal neovascularization and contemporary antiangiogenic therapeutics.
    Hsu CC; Chang HM; Lin TC; Hung KH; Chien KH; Chen SY; Chen SN; Chen YT
    J Chin Med Assoc; 2015 Jun; 78(6):323-30. PubMed ID: 25687646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemokines and ocular pathology caused by corneal infection with herpes simplex virus.
    Kumaraguru U; Davis I; Rouse BT
    J Neurovirol; 1999 Feb; 5(1):42-7. PubMed ID: 10190689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Herpes keratitis.
    Rowe AM; St Leger AJ; Jeon S; Dhaliwal DK; Knickelbein JE; Hendricks RL
    Prog Retin Eye Res; 2013 Jan; 32():88-101. PubMed ID: 22944008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substance P in the corneal stroma regulates the severity of herpetic stromal keratitis lesions.
    Twardy BS; Channappanavar R; Suvas S
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8604-13. PubMed ID: 21969295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-17 enhanced immunoinflammatory lesions in a mouse model of recurrent herpetic keratitis.
    Xia L; Zhang S; Cao Z; Hu Y; Yang H; Wang D
    Microbes Infect; 2013 Feb; 15(2):126-39. PubMed ID: 23159245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrastromal bevacizumab injection for corneal neovascularization in herpetic stromal keratitis.
    Berrozpe-Villabona C; Santos-Bueso E; Díaz-Valle D; Gegúndez-Fernández JA; Benitez-Del-Castillo JM; Castellar-Cerpa J; Ventura-Abreu N
    J Fr Ophtalmol; 2015 Oct; 38(8):776-7. PubMed ID: 26342658
    [No Abstract]   [Full Text] [Related]  

  • 37. Morphometric analysis of postoperative corneal neovascularization after high-risk keratoplasty: herpetic versus non-herpetic disease.
    Altenburger AE; Bachmann B; Seitz B; Cursiefen C
    Graefes Arch Clin Exp Ophthalmol; 2012 Nov; 250(11):1663-71. PubMed ID: 22419035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HSV immune complex (HSV-IgG: IC) and HSV-DNA elicit the production of angiogenic factor VEGF and MMP-9.
    Hayashi K; Hooper LC; Detrick B; Hooks JJ
    Arch Virol; 2009; 154(2):219-26. PubMed ID: 19115032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic stigmasterol derivatives inhibit capillary tube formation, herpetic corneal neovascularization and tumor induced angiogenesis: Antiangiogenic stigmasterol derivatives.
    Michelini FM; Lombardi MG; Bueno CA; Berra A; Sales ME; Alché LE
    Steroids; 2016 Nov; 115():160-168. PubMed ID: 27623061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The atypical chemokine receptor-2 fine-tunes the immune response in herpes stromal keratitis.
    Yu T; Schuette F; Christofi M; Forrester JV; Graham GJ; Kuffova L
    Front Immunol; 2022; 13():1054260. PubMed ID: 36518752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.